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Abstract
Infections of body tissue by Staphylococcus aureus are quickly
followed by degradation of connective tissue. Patients with
rheumatoid arthritis are more prone to S. aureus-mediated
septic arthritis. Various types of collagen form the major
structural matrix of different connective tissues of the body.
These different collagens are degraded by specific matrix
metalloproteinases (MMPs) produced by fibroblasts, other
connective tissue cells, and inflammatory cells that are induced
by interleukin-1 (IL-1) and tumor necrosis factor (TNF). To
determine the host's contribution in the joint destruction of S.
aureus-mediated septic arthritis, we analyzed the MMP
expression profile in human dermal and synovial fibroblasts upon
exposure to culture supernatant and whole cell lysates of S.
aureus. Human dermal and synovial fibroblasts treated with cell
lysate and filtered culture supernatants had significantly
enhanced expression of MMP-1, MMP-2, MMP-3, MMP-7,
MMP-10, and MMP-11 compared with the untreated controls (p
< 0.05). In the S. aureus culture supernatant, the MMP
induction activity was identified to be within the molecular-
weight range of 30 to >50 kDa. The MMP expression profile was
similar in fibroblasts exposed to a combination of IL-1/TNF.
mRNA levels of several genes of the mitogen-activated protein
kinase (MAPK) signal transduction pathway were significantly
elevated in fibroblasts treated with S. aureus cell lysate and
culture supernatant. Also, tyrosine phosphorylation was
significantly higher in fibroblasts treated with S. aureus
components. Tyrosine phosphorylation and MAPK gene
expression patterns were similar in fibroblasts treated with a
combination of IL-1/TNF and S. aureus. Mutants lacking
staphylococcal accessory regulator (Sar) and accessory gene
regulator (Agr), which cause significantly less severe septic
arthritis in murine models, were able to induce expression of
several MMP mRNA comparable with that of their isogenic
parent strain but induced notably higher levels of tissue
inhibitors of metalloproteinases (TIMPs). To our knowledge, this
is the first report of induction of multiple MMP/TIMP expression
from human dermal and synovial fibroblasts upon S. aureus
treatment. We propose that host-derived MMPs contribute to
the progressive joint destruction observed in S. aureus-
mediated septic arthritis.
Agr = accessory gene regulator; AHO = acute hematogenous osteomyelitis; AMV = avian myeloblastoid virus; AP-1 = activation protein; ATCC = 
American Type Culture Collection; DMEM = Dulbecco's modified Eagle's medium; ELISA = enzyme-linked immunosorbent assay; ERK = extracellular 
signal regulated kinase; FBS = fetal bovine serum; GAPDH = glyceraldehyde phosphate dehydrogenase; IFN = interferon; IL = interleukin; IL-1ra = 
interleukin-1 receptor antagonist; JNK = c-jun N-terminal kinase; LT = lymphotoxin; mAb = monoclonal antibody; MAPK = mitogen-activated protein 
kinase; MMP = matrix metalloproteinase; MRSA = multidrug-resistant Staphylococcus aureus; OA = osteoarthritis; PCR = polymerase chain reaction; 
PGN = peptidoglycan; RA = rheumatoid arthritis; RT-PCR = reverse transcription-polymerase chain reaction; SA = septic arthritis; Sar = staphylo-
coccal accessory regulator; SSTI = skin and soft tissue infection; TIMP = tissue inhibitor of metalloproteinases; TLR = Toll-like receptor; TNF = tumor 
necrosis factor.Arthritis Research & Therapy    Vol 8 No 6    Kanangat et al.
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Introduction
Staphylococcus aureus is the most common cause of septic
arthritis (SA) [1,2]. SA has shown no change in incidence in
spite of advances in antimicrobial therapy and is responsible
for residual functional impairment and for a high mortality rate
among debilitated patients. Risk factors include older age, dia-
betes mellitus, rheumatoid arthritis (RA), immunodeficiency,
and a pre-existing joint disease. In SA, S. aureus contributes
to more than two thirds of identified organisms [3,4]. In an epi-
demiological study of SA in an adult population of 116
patients by Abid and colleagues [5] between 1999 and 2004,
S. aureus was the most common organism isolated from blood
as well as synovial fluid (18.8%). Cleeman and colleagues [6]
studied 23 culture-positive cases of SA of the glenohumeral
joint between 1986 and 2000, and 52% had a different pri-
mary site of infection identified, 70% of which were S. aureus-
positive and 17% of which were methicillin-resistant. In a ret-
rospective analysis by Moumile and colleagues [7] of the bac-
terial etiology of acute osteoarticular infections in 406 children
with clinically suspected osteoarticular infections, 74 (18%)
had a positive bacterial culture: 38 cases of SA and 36 cases
of bone infections (osteitis and osteomyelitis), the most com-
monly recovered pathogen being S. aureus (44%). Goergens
and colleagues [8] reviewed the clinical presentation, man-
agement, and organisms responsible for acute hematogenous
osteomyelitis (AHO) and SA in Australia between 1998 to
2002, and S. aureus was the most common identifiable caus-
ative organism, accounting for 76% of isolated organisms in
AHO and 39% of isolated organisms in SA. S. aureus remains
the most common organism causing AHO and SA, and multi-
drug-resistant S. aureus (MRSA) is on the increase as well.
Progressive joint destruction despite appropriate antibiotic
therapy and synovial fluid aspiration may indicate a potential
role for host-derived proteases. Several matrix metalloprotein-
ases (MMPs) are induced in host cells in response to infec-
tious stimuli. Normally, MMPs assist in clearing infections,
initiating immune responses, and in tissue remodeling [9].
Excessive MMPs cause matrix degradation and joint destruc-
tion as in various forms of arthritis [10].
Cytokines interleukin (IL)-1, IL-6, tumor necrosis factor (TNF)-
α, and interferons (IFN-α and IFN-γ) are released from host
cells in response to S. aureus infection and these are potent
inducers of MMPs [11-15]. Staphylococcal capsule polysac-
charides, toxins, cell wall-attached adhesions, and possibly
also the chromosomal DNA are virulence determinants in S.
aureus arthritis. These bacterial components might affect the
innate immune response and inflammation [1]. Alternatively,
the bacterial products, secreted or intracellular, could directly
affect the transcriptional machinery or signal transduction
pathways related to MMP expression. Previous studies have
shown the induction of proteolytic enzymes in chondrocytes in
response to bacteria-free culture supernatants from S. aureus
[16]. Also, peptidoglycan (PGN) from S. aureus has been
shown to be capable of inducing arthritis [17]. A recent study
showed that S. aureus PGN induces MMP-1, -3, and -13 in
human synovial fibroblasts [18]. Purified PGN is chemically
modified and may not really represent the native PGN. Also,
there is a wide variety of bacterial components, including the
superantigens, cell wall components, and extracellular toxins,
which could stimulate the host cells. The full potential of syno-
vial fibroblasts in terms of multiple MMP expression in
response to S. aureus components has not yet been
addressed. To determine the global impact of S. aureus com-
ponents on primary human fibroblasts with respect to MMP
expression, we exposed de-identified normal human dermal
fibroblasts and synovial fibroblasts derived from de-identified
patients with RA and osteoarthritis (OA) to whole cell lysate
and culture supernatants (whole and fractionated) derived
from S. aureus wild-type and mutant strains that induce less
severe SA in murine models.
Materials and methods
Bacterial strains
S. aureus strain isolated from a patient with SA was obtained
from American Type Culture Collection (ATCC) (Manassas,
VA, USA). A de-identified clinical isolate (U1) and mutants
lacking staphylococcal accessory gene regulator (U155: Sar-/
-) and accessory gene regulator (U929: Agr-/-) and a strain
lacking both Sar A and Agr (Sar-Agr-/-) derived from that clini-
cal isolate were obtained from M. Smeltzer and were used in
this study. The U155 strain was grown in the presence of tet-
racycline (5 μg/ml); U929 was grown in presence of kanamy-
cin (50 μg/ml) and neomycin (50 μg/ml); and U930 was
grown in the presence of tetracycline (5 μg/ml), 50 μg/ml kan-
amycin, and 50 μg/ml neomycin/ml for selection of the respec-
tive mutants. Strains grown in the presence of antibiotics were
centrifuged, washed, and resuspended in Dulbecco's modi-
fied Eagle's medium (DMEM)/F-12 medium for inoculation in
order to remove the antibiotics.
Preparation of whole and fractionated bacterial culture 
supernatants and bacterial cell lysates
To collect supernatants and bacterial cell pellets for experi-
ments, bacterial strains (isogenic parent strain and mutants
strains) were grown in DMEM/F-12 containing 2% fetal bovine
serum (FBS) without any antibiotics. Supernatants and cell
pellets were obtained by centrifugation from 12-hour bacterial
cultures. The supernatants were sterilized through 0.22-μm fil-
ters to ensure that they were free of any bacteria. The cell pel-
lets were treated with lysostaphin (20 U/ml) for 20 minutes at
37°C followed by repeated freezing and thawing. The lysates
were clarified by centrifugation at 12,000 g for 20 minutes and
were filtered through 0.22-μm filters. The ATCC strain was
also grown in the presence of 5 and 15 ng/ml recombinant
human rhIL-1β (R&D Systems, Inc., Minneapolis, MN, USA).
The cell lysates were prepared as described above. Total pro-
tein concentrations were measured by the calorimetric method
(Bio-Rad, Hercules, CA, USA) in accordance with the manu-
facturer's instructions. The culture supernatants from theAvailable online http://arthritis-research.com/content/8/6/R176
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ATCC strain were fractionated into <30, 30 to 50, and >50
kDa molecular-weight fractions using respective Centricon fil-
ter centrifugation.
Fibroblast cultures
Dermal fibroblasts from de-identified normal volunteers and
synovial fibroblasts from de-identified RA patients and OA
patients were maintained in DMEM/F-12 containing 10%
FBS, 100 U/ml penicillin, and 100 μg of streptomycin. All the
fibroblast cell lines were from a cell culture bank established
by A. Postlethwaite in accordance with the full approval of the
institutional review board of the University Of Tennessee
Health Science Center (Memphis, TN, USA).
Treatment of fibroblasts with S. aureus supernatants, 
lysates, and rhIL-1β/rhTNF-α
For studies measuring MMP production, 105 fibroblasts har-
vested by trypsinization were added to each well of 24-well tis-
sue-culture plates (Falcon; Falcon Plastics, Inc., Washington,
PA, USA). Three days later, confluent monolayers of fibrob-
lasts were treated with phosphate-buffered saline, 25 μg of
total proteins from bacterial cell lysates, 25 μg of total proteins
from culture supernatants, and 15 μg of protein from each
fraction of culture supernatant per well (only from ATCC
strain). Fibroblasts were cultured in an incubator containing a
humidified atmosphere containing 5% CO2 at 37°C. Fibrob-
lasts were cultured for 8 hours for RNA analysis and 48 hours
for protein analysis. Fibroblasts were also treated with a com-
bination of 10 μg each of rhIL-1β/TNF-α for 8 hours and 48
hours. For mRNA analysis, cells were harvested after 8 hours
of respective treatments, and total RNA was isolated using
TRI-Reagent (Sigma-Aldrich, St. Louis, MO, USA) followed by
isopropanol precipitation. The fibroblast culture supernatants
were collected 48 hours after respective treatments and cen-
trifuged to remove any cell debris. All samples were stored at
-80°C until analyzed.
Fractionation of S. aureus culture supernatants
Culture supernatants from S. aureus were purified using the
Amicon Centricon filter device from Millipore Corporation (Bill-
erica, MA, USA). Using this device, an approximately 2.0-ml
volume was concentrated into an approximately 30-μl volume.
Using the 10,000, 30,000, and 50,000 kDa cutoff filter
devices, we fractionated the whole culture supernatants to
<30, 30 to 50, and >50 kDa fractions.
Assay for MMP and tissue inhibitor of 
metalloproteinases mRNAs
Total RNA was reverse-transcribed into cDNAs by using avian
myeloblastoid virus (AMV) RTase and Oligo dT primers. Qual-
itative profiling of multiple MMP mRNAs was performed using
a Multi-MMP-mRNA kit from SuperArray Bioscience Corpora-
tion (Frederick, MD, USA) in accordance with the manufac-
turer's protocol. Relative quantification of MMP mRNAs was
performed using SYBR green real-time polymerase chain
reaction (PCR) on the cDNAs obtained. Assays for MMP-1, -
2, -3, -7, -8, -9, -10, -11, -12, -13, and -14 were performed.
Gene-specific oligonucleotide primers for tissue inhibitor of
metalloproteinases (TIMP)-1, TIMP-2, and TIMP-3 were syn-
thesized at Integrated DNA Technologies (Coralville, IA, USA).
The messages of TIMP mRNAs were quantified using SYBR
green real-time reverse transcription-PCR (RT-PCR). The
message levels were expressed as ratios of the threshold
cycle values of respective MMP or TIMP messages to those of
the housekeeping gene glyceraldehyde phosphate dehydro-
genase (GAPDH).
Assays for MMP protein
Multiple MMP proteins were determined using an MMP pro-
tein array kit from RayBiotech, Inc. (Norcross, GA, USA)
strictly following the manufacturer's instructions. Briefly, the
100 μl of culture supernatants was applied to the membrane
with arrayed antibodies. After blocking the free spaces on the
membrane, a cocktail of biotin-labeled antibodies was added
and the membranes were incubated for 2 hours at ambient
temperature. After repeated washing, horseradish peroxidase-
conjugated streptavidin was added onto the membrane and
incubated for 2 hours at ambient temperature. After extensive
washing, the detection buffer was added and the signals were
detected by capturing the enhanced chemiluminiscence onto
a Kodak x-omat AR film (Eastman Kodak, Rochester, NY,
USA). The film was photographed and scanned for
documentation.
Semiquantitative profiling of mRNAs of MAPK family
A human MAPK gene family multigene-12 RT-PCR profiling kit
(Superarray Bioscience Corporation) was used for the qualita-
tive assessment of extracellular signal regulated kinase (ERK)
2/MAPK2, ERK1, MAPK4, ERK3, ERK5, c-jun N-terminal
kinase (JNK) 1, JNK2, JNK3, p38b MAPK, p38g MAPK, and
p38delta MAPK mRNA in fibroblasts in response to S. aureus
culture supernatant and cell lysate. Total RNA was reverse-
transcribed into cDNAs using AMV RTase and Oligo dT prim-
ers, and the messages were amplified using the primer sets
supplied by the manufacturer. The expression level of the
housekeeping gene GAPDH  in each sample was used to
assess the qualitative differences in respective message levels
between samples. The experiments were repeated three times
and each time the assays were set up in duplicate. The PCR
products were analyzed on a 2% agarose gel and were
stained with SYBR green. The intensities of the bands were
estimated by densitometric scanning software from Alpha
Innotech Corporation (San Leandro, CA, USA). The values
expressed are ratios of the densities of the MAPK genes to
those of the housekeeping gene GAPDH.
Cell-based enzyme-linked immunosorbent assay for 
tyrosine phosphorylation
A cell-based phosphotyrosine enzyme-linked immunosorbent
assay (ELISA) kit from RayBiotech, Inc., was used toArthritis Research & Therapy    Vol 8 No 6    Kanangat et al.
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quantitate tyrosine phosphorylation in human dermal fibrob-
lasts in response to S. aureus components and IL-1/TNF.
Approximately 30,000 cells were seeded into each well in a
96-well plate. Cells were incubated at 37°C, 5% CO2 over-
night. The cells were then exposed to S. aureus cell lysate (25
μg/ml), S. aureus (ATCC) culture supernatant (25 μg/ml), or
10 ng/ml each of rhIL-1β and rhTNF-α for 30 minutes. The
medium was removed from the wells, and the cells were
treated with the fixing solution followed by quenching solution.
The fixed, quenched cells were treated with blocking solution
for 3 hours at ambient temperature, and after washing the cells
were exposed to anti-phosphotyrosine-horseradish peroxi-
dase for 1 hour followed by washing and the addition of one-
step substrate solution. The plates were incubated in the sub-
strate solution for 30 minutes, the color reaction was stopped,
and the optical densities were read at 450 nm. The experi-
ments were repeated three times and each time the experi-
ments were run in triplicates.
Statistical analysis
Each treated sample was compared with the untreated sample
using Student's test. Sigma Stat (Systat Software, Inc., San
Jose, CA, USA) program was used for statistical computation,
and Sigma Plot (Systat Software, Inc.) was used to create
graphs. A p value of less than 0.05 was considered significant.
Results
Induction of multiple MMP proteins by S. aureus in 
human dermal fibroblasts
Culture supernatant and cell lysate from S. aureus (ATCC)
induced the expression of immunoreactive proteins of MMP-1,
MMP-2, MMP-10, and MMP-13 in dermal fibroblasts (Figure
1). Upregulation of TIMP-1 and TIMP-2 was also noted in S.
aureus culture supernatant and cell lysate-treated fibroblasts.
There were no notable changes in the expression levels of
other MMP proteins (MMP-8 and MMP-9) in the cells in
response to treatment. The expression pattern and level of
expression were similar in S. aureus components and IL-1β/
TNF-α-treated fibroblasts.
Induction of multiple MMP mRNAs by S. aureus in 
human dermal and synovial fibroblasts
Multiple MMP mRNA profile in dermal and synovial fibroblasts
in response to S. aureus components was determined by
SYBR green real-time PCR. Culture supernatants and cell
lysate from S. aureus significantly enhanced the expression of
multiple MMP mRNAs (namely, MMP-1, -2, -3, -7, -10, and -
11; p < 0.05). As in the case of MMP protein expression pat-
tern, the response of the fibroblasts in terms of MMP mRNA
expression was similar in S. aureus component-treated and
rhTNF-α- and rhIL-1β-treated fibroblasts (Figure 2). Unlike
untreated dermal fibroblasts (Figure 2), untreated synovial
fibroblasts from patients with RA (Figure 3a) and OA (Figure
3b) had higher basal multiple MMP mRNA expression, indicat-
ing an activated status of the synovial fibroblasts from a path-
ological site. Similar to the dermal fibroblasts, most MMP
mRNAs tested were elevated in RA and OA fibroblasts in
response to S. aureus components. Levels of significantly ele-
vated MMPs (MMP-1, -2, -3, -7, -10, and -11; p < 0.05) are
shown in Figure 3a,b. The MMP mRNA expression pattern in
response to IL-1β/TNF-α and S. aureus lysate was similar in
RA and OA fibroblasts (Figure 3a,b) as well. Interestingly, no
significant differences were noted in MMP-13 mRNA levels
between the treated and untreated fibroblasts. All other MMPs
tested were expressed at very low levels, could not be quanti-
fied, and hence were not included in the graph.
Two more dermal fibroblast lines, RASF and OASF cell lines,
were tested for multiple MMP mRNA expression profile upon
exposure to S. aureus culture supernatants and bacterial cell
lysates. Essentially the same profile as described above was
obtained from the additional cell lines (data not shown).
Because fibroblasts are heterogeneous in terms of their origin
and some of their features, it is likely that fibroblasts from dif-
ferent sources may respond slightly differently in terms of
MMP expression.
Potentiation of MMP protein expression in human 
fibroblasts by S. aureus grown in presence of rhIL-1β
We have observed significant changes in gene expression in
S. aureus grown in the presence of rhIL-1β (manuscript sub-
mitted). To test whether S. aureus grown in the presence of
rhIL-1β would have any impact on MMP expression, dermal
fibroblasts were exposed to 25 μg/ml per well bacterial cell
lysate obtained from S. aureus grown in the presence of 5 or
15 ng/ml rhIL-1β. The supernatants were collected and
expression of multiple MMP protein was assessed by multi-
MMP-Array kit from RayBiotech, Inc., as described previously.
The data presented in Figure 4 show that production of MMP-
2, -3, and -8 is greater in fibroblasts treated with cell lysate
obtained from the S. aureus strain grown in the presence of
rhIL-1β. TIMP-4 expression was also slightly enhanced in
fibroblasts treated with lysate obtained from the S. aureus
grown in the presence of 15 ng/ml IL-1β.
Induction of MMP mRNA in human dermal fibroblasts by 
fractionated culture supernatants from S. aureus
The MMP-inducing active components in the culture superna-
tants were mostly in the 30 to 50 and >50 kDa molecular-
weight range as evidenced by significantly elevated expres-
sion of MMP-1 and MMP-3 by Centricon fractions 30 to 50
and >50 kDa in dermal fibroblasts (Figure 5; p  < 0.05).
Although the fractions are not identified beyond their molecu-
lar weight, this does rule out some of the already-characterized
low-molecular-weight extracellular (secreted) products of S.
aureus.Available online http://arthritis-research.com/content/8/6/R176
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MMP mRNA induction by Sar, Agr, and Sar/Agr mutants 
of S. aureus
Blevins and colleagues [19] have shown that S. aureus strains
lacking the regulatory loci Sar or Agr result in less severe SA
and osteomyelitis in murine models of these diseases. We
therefore tested the ability of cell lysates and culture superna-
tants obtained from these mutants and their isogenic parent
strain to induce MMP-1 and MMP-3 mRNAs in human dermal
fibroblasts. The mutants and isogenic strains enhanced MMP-
1 and MMP-3 production by fibroblasts to a similar degree
(Figure 6).
Induction of TIMP mRNA expression in human 
fibroblasts by S. aureus wild-type and Sar/Agr mutants
TIMPs are members of the MMP gene family and play an
important role in the overall availability of active MMPs. Hence,
it is important to determine the TIMP expression profile of
fibroblasts in response to S. aureus and S. aureus compo-
nents. In our current study, we used culture supernatants
obtained from an S. aureus strain isolated from synovial fluid
of a patient with SA (ATCC), a clinical isolate (U1), and its Agr/
Sar A double-loci-deleted mutant U930 (strains obtained from
M. Smeltzer). The results presented in Figure 7a,b indicate a
notably increased induction of TIMP-1, -2, and -3 mRNA by the
Agr/Sar A deletion mutant (U930) of the isogenic parent wild-
type strain (U1) and the ATCC strain isolated from the syn-
ovium of a patient with arthritis.
It may be speculated that the effective MMP available upon
infection with Agr/Sar deletion mutant is likely to be less com-
pared with the parent isogenic strain. However, further studies
to examine expression of other MMPs as well as analysis to
Figure 1
Induction of multiple matrix metalloproteinase (MMP) protein by Staphylococcus aureus in human dermal fibroblasts Induction of multiple matrix metalloproteinase (MMP) protein by Staphylococcus aureus in human dermal fibroblasts. Confluent monolayers of 
human primary dermal fibroblasts were exposed to (I) phosphate-buffered saline, (II) 25 μg/well of total protein from clarified whole cell lysates of S. 
aureus cells, (III) 25 μg of total protein from the filtered culture supernatant of S. aureus, and (IV) treated with 10 ng/m each of interleukin-1β/tumor 
necrosis factor-α (IL-1β/TNF-α) for 48 hours. The fibroblast culture supernatants were harvested and the MMPs and tissue inhibitors of metallopro-
teinases (TIMPs) were detected using the MMP-Array kit from RayBiotech, Inc. (Norcross, GA, USA). Culture supernatant and cell lysate from S. 
aureus induced the expression of MMP-1, MMP-2, MMP-10, and MMP-13. A similar pattern was observed in IL-1β/TNF-α-treated fibroblasts, which 
were slightly more intense. There was upregulation of both TIMP-1 and TIMP-2 as well.Arthritis Research & Therapy    Vol 8 No 6    Kanangat et al.
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estimate enzymatically active MMPs by zymogram will be
required to determine whether genes under the control of Sar
or Agr have any effect on the expression of functional MMPs.
MAPK gene expression in synovial fibroblasts from 
patients with RA and OA
Members of the MAPK gene family (such as ERK1/2 and
p38MAPK) are involved in the induction of MMPs through acti-
vation protein (AP-1) transcription factors. We therefore ana-
lyzed the mRNA expression levels of 12 members of the MAPK
family using the MultiGene-12 RT-PCR profiling kit from
Superarray Bioscience Corporation. Synovial fibroblasts
obtained from patients with RA and OA were exposed to 25
μg of total proteins from bacterial culture supernatant or cell
lysate, and total RNA was isolated 6 hours later, reverse-tran-
scribed, and assayed for mRNA of 12 MAPK genes. Several
of the MAPK family members were upregulated. The ratio
between the intensities of each MAPK gene to that of GAPDH
is depicted in Figure 7. Significant increases in ERK2, ERK1,
MAPK4, JNK1, JNK2, p38b, and p38g were observed in der-
mal fibroblasts treated with S. aureus culture supernatant and
cell lysate-treated compared with untreated fibroblasts (Figure
8a; p < 0.05) and in synovial fibroblast-treated compared with
untreated fibroblasts (Figure 8b; p < 0.05). Similar increases
in these MAPK gene family members were noted in IL-1β/TNF-
α-treated fibroblasts (Figure 8a,b; p < 0.05).
Tyrosine phosphorylation in human dermal fibroblasts 
exposed to S. aureus culture supernatant
Using a cell-based ELISA system (RayBiotech, Inc.), tyrosine
phosphorylation was assessed in human dermal fibroblasts
after 30-minute exposure to 25 μg of total protein from filtered
culture supernatant of S. aureus and in fibroblasts treated with
10 ng/ml each of rhIL-1β and rhTNF-α. There was a significant
increase in phosphotyrosine in S. aureus culture supernatant-
treated cells, similar to that observed in IL-1β/TNF-α-treated
cells (Figure 9; p < 0.05).
Overall, our data indicate that S. aureus components induce
multiple MMP expression in human dermal and synovial
fibroblasts and that the response is similar to that induced by
IL-1β/TNF-α. The expression pattern of MAPK gene expres-
sion also indicates the possibility of a signal transduction path-
way akin to that induced by the inflammatory cytokine pathway.
Our data also indicate that the virulence gene loci (namely, Sar
and Agr) are not determinants of S. aureus-induced MMP
mRNA expression.
Discussion
We have shown that the culture supernatants and whole bac-
terial lysate from S. aureus induce multiple MMPs from human
dermal and synovial fibroblasts. Several genes of the MAPK
pathways were upregulated in treated fibroblasts, and phos-
photyrosine proteins were significantly elevated. Using frac-
tionated S. aureus culture supernatants, we have shown that
the best MMP induction was by components that fall within the
molecular-weight range of 30 to 50 kDa. Interestingly, culture
supernatants and bacterial cell lysates obtained from S.
aureus  grown in the presence of rhIL-1β induced notably
higher levels of MMPs compared with S. aureus grown in the
absence of rhIL-1β. The overall spectrum of MMP induction by
S. aureus components was similar to that elicited by a combi-
nation of IL-1β and TNF-α. Our in vitro MMP mRNA expression
analysis showed that mutants lacking Sar A and Agr loci and
their parent isogenic strain induced comparable levels of MMP
mRNAs; however, the mutant strains induced notably higher
levels of TIMP-1, -2, and -3 mRNAs in human fibroblasts. To
our knowledge, this is the first report on multiple MMP/TIMP
induction by fractionated S. aureus culture supernatants and
whole bacterial cell lysates in human dermal and synovial
fibroblasts.
SA is the most commonly reported bacterial complication of
RA. The risk is highest in severe, longstanding, seropositive
disease. The clinical presentation of joint infection is frequently
atypical, and in 25% of cases, the infection is polyarticular. S.
aureus is the most common causative organism [20]. Staphy-
lococcal infections can be hard to eradicate from RA joints
and often surgery is required [21]. TNF-α plays an important
Figure 2
Induction of multiple matrix metalloproteinase (MMP) mRNAs in human  dermal fibroblasts (HDF) by Staphylococcus aureus Induction of multiple matrix metalloproteinase (MMP) mRNAs in human 
dermal fibroblasts (HDF) by Staphylococcus aureus. Confluent monol-
ayers of fibroblasts were exposed to 25 μg/well of total protein from 
culture supernatants (SUP), 25 μg/well of total protein from bacterial 
cell lysate, or 10 ng/ml each of rhTNF-α and rhIL-1β for 8 hours. Total 
RNA was isolated and reverse-transcribed. The cDNA was amplified 
and quantified using SYBR green real-time polymerase chain reaction. 
All the MMPs tested were expressed in dermal fibroblasts exposed to 
S. aureus components. Both culture supernatants and cell lysate from 
S. aureus significantly enhanced the expression of multiple MMPs 
(namely, MMP-1, -2, -3, -7, -10, and -11; p < 0.05). The dermal fibrob-
lasts responded similarly to a combination of rhTNF-α and rhIL-1β in 
terms of multiple MMP mRNA expression. IL, interleukin; TNF, tumor 
necrosis factor.Available online http://arthritis-research.com/content/8/6/R176
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role in the host defense against infection. Inhibition of its activ-
ity could therefore be anticipated to augment the risk of infec-
tion in patients with RA. The reasons for the predominance of
S. aureus in SA and the mechanisms of pathogenecity are not
yet fully understood. The synovium of patients with RA is rich
in IL-1β. We have previously shown that S. aureus can bind to
IL-1β and use it as a growth factor [22]. A recent report by
McLaughlin and Hoogewerf [23] showed that the growth and
replication of S. aureus in a biofilm are significantly increased
by the addition of rhIL-1β. We have also observed that rhIL-1
can modulate the gene expression in S. aureus including the
bicomponent leukotoxins and some of the surface adhesion
molecules collectively called MSCRAMMs (microbial surface
components recognizing adhesive matrix molecules) in addi-
tion to some of the genes in the pathogenecity island of S.
aureus (Kanangat and colleagues, manuscript submitted). We
speculate that the IL-1-rich synovial milieu might potentially
contribute to the increased frequency of S. aureus in patients
with RA-SA and that the host-derived MMPs induced by S.
aureus might accelerate the pathogenesis of SA.
Our data on the induction of MMPs by S. aureus culture super-
natants and cell lysates compares well with the previous report
by Williams and colleagues [16], who demonstrated MMP-1
Figure 3
Induction of multiple matrix metalloproteinase (MMP) mRNAs in human synovial fibroblasts (SFs) by Staphylococcus aureus Induction of multiple matrix metalloproteinase (MMP) mRNAs in human synovial fibroblasts (SFs) by Staphylococcus aureus. MMP mRNA expres-
sion profile in confluent monolayers of SFs obtained from de-identified (a) rheumatoid arthritis (RA) and (b) osteoarthritis (OA) patients treated with 
culture supernatants (SUP) (25 μg of total protein/well) and cell lysates (25 μg of total protein/well) were determined using SYBR green real-time 
reverse transcription-polymerase chain reaction. Unlike untreated dermal fibroblasts, untreated SFs from RA and OA patients had higher basal multi-
ple MMP mRNA expression. Similar to the dermal fibroblasts, most MMP mRNAs tested were elevated in RA and OA fibroblasts in response to S. 
aureus cell lysate and culture supernatants. Levels of significantly elevated MMPs (MMP-1, -2, -3, -7, -10, and -11; p < 0.05) are shown in (a) and 
(b). The MMP mRNA expression pattern in response to IL-1β/TNF-α and S. aureus lysate was similar in RA and OA fibroblasts. IL, interleukin; TNF, 
tumor necrosis factor.Arthritis Research & Therapy    Vol 8 No 6    Kanangat et al.
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and -3 expression by articular cartilage upon exposure to puri-
fied culture supernatant from S. aureus. We have extended
this observation by showing expression of a wide range of
MMPs, including MMP-7 (with a proven in vivo association
with S. aureus-induced SA), by human synovial as well as der-
mal fibroblasts in response to S. aureus components. The pro-
file was similar to that induced by a combination of IL-1/TNF,
which might indicate the involvement of an inflammatory
cytokine-mediated pathway in the observed induction of
MMPs by S. aureus.
S. aureus culture supernatants and cell lysates have a wide
variety of proteins, and identification of the components that
are actually responsible for inducing the MMP induction is
essential to determine the mechanisms of induction as well as
to rationally design intervening agents against bacterial prod-
ucts. Toward this we end, we have narrowed down the possi-
ble candidates to molecular-weight groups of the range of
>30 to 50 based on our experiments using Centricon filtration
of the culture supernatants. Because the molecular weight of
the chemically purified PGN used in previous studies is not
known, we are not in a position to determine whether PGN is
included in the stated molecular-weight range. At this time, we
have not identified the components beyond the molecular
level; nevertheless, this rules out the possibility of some of the
recently described low-molecular-weight proteins such as the
19-kDa extracellular fibrinogen-binding protein that inhibits
complement activation [24]. Certain complement components
have been reported to activate MMPs [25]. The results of the
fractionated supernatants also tentatively rule out the possibil-
ity of the exotoxin akin to the toxic shock syndrome protein
described by Ren and colleagues [26] and the enterotoxin H
described by Su and Wong [27]. Although speculative at this
juncture, it is possible that the active components in the 30 to
50 kDa could potentially be the novel 38.5-kDa protein named
extracellular matrix-binding protein described by Hussain and
colleagues [28].
Joint destruction by S. aureus is very rapid if not treated appro-
priately. Although direct erosion of the joint architecture by S.
aureus proteases/toxins cannot be completely ruled out, con-
tinued degradation of extracellular matrix component and the
joint architecture even after clearing the infection and debris
from the joint cavity indicates the possibility of host-derived
proteases in causing joint pathology. Previous studies have
shown the release of active MMP-1 and MMP-3 by human
articular cartilage upon exposure to sterile purified S. aureus
culture medium [16]. The enzymatic profile was similar to that
induced by IL-1. The authors concluded that the collagenase
and stromelysin released by articular cartilage could contrib-
ute to extensive destruction of human cartilage in SA. The exo-
proteases of S. aureus have been proposed as virulence
factors during S. aureus infections. Calander and colleagues
[29], using wild-type S. aureus strain 8325-4 and its mutants
lacking aureolysin, serine protease, and cysteine protease,
demonstrated in a murine SA model that inactivation of the
Figure 4
Potentiation of matrix metalloproteinase (MMP) protein expression in human fibroblasts by Staphylococcus aureus grown in the presence of recom- binant human interleukin (rhIL)-1β Potentiation of matrix metalloproteinase (MMP) protein expression in human fibroblasts by Staphylococcus aureus grown in the presence of recom-
binant human interleukin (rhIL)-1β. The cell pellets from S. aureus grown in the presence or absence of rhIL-1β were washed repeatedly to prepare 
cell lysate. Enzyme-linked immunosorbent assay (R&D Systems, Inc., Minneapolis, MN, USA) was carried out to make sure that the bacterial cell 
lysate was devoid of any traces of rhIL-1β. Confluent monolayers of human dermal fibroblasts were exposed to 25 μg/well of IL-1β-free cell lysate 
obtained from S. aureus for 48 hours. The supernatants were collected and expression of multiple MMP protein was assessed using multi-MMP-
Array kit from RayBiotech, Inc. (Norcross, GA, USA) as described in the text. The data presented show that MMP-2, -3, and 8 are relatively more 
expressed in fibroblasts treated with S. aureus cell lysate obtained from strain grown in the presence of 5 and 15 ng/ml rhIL-1β. Tissue inhibitor of 
metalloproteinases (TIMP)-4 expression was also slightly enhanced in fibroblasts treated with S. aureus lysate obtained from strain treated with 15 
ng/ml IL-1β.Available online http://arthritis-research.com/content/8/6/R176
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exoprotease genes did not affect the frequency or the severity
of joint pathology. Intra-articular injection of PGN into murine
joints triggered arthritis in a dose-dependent manner [17]. A
single injection of this compound caused massive infiltration of
macrophages and polymorphonuclear cells with signs of carti-
lage and/or bone destruction, lasting for at least 14 days,
indicating that PGN exerts a central role in joint inflammation
triggered by S. aureus [17]. The significance of MMP-7
expression in SA was examined by Gjertsson and colleagues
[30] using MMP-7-deficient mice and congeneic controls.
These mice were inoculated (intravenously) with an arthri-
togenic dose of S. aureus LS-1, and the mice deficient for
MMP-7 developed significantly less-severe arthritis both clini-
cally and histologically despite significantly increased num-
bers of live bacteria within the internal organs. Interestingly, in
vitro responses to staphylococcal antigens and superantigens
were not different between MMP-7+/+ and MMP-7-/- mice in
terms of cytokine production. MMP-7 facilitates migration of
both macrophages and neutrophils, and the authors therefore
conclude that modulation of SA by MMP-7 might be due to
changes in peripheral leukocyte distribution. Also, studies by
Wang and colleagues [31] have shown that addition of PGN
to whole human blood resulted in enhanced levels of MMP-9
within 1 hour and significant enhancement of MMP-9 secre-
tion from the neutrophils was obvious within 30 minutes of
incubation with S. aureus PGN.
Host-cell MMPs are necessary for efficient clearance of infec-
tion by accelerating the recruitment of effector cells to kill path-
ogen and to resolve inflammation and for subsequent tissue
remodeling [9]. However, excessive MMPs after infection and
inflammation may cause tissue damage leading to immunopa-
thology. MMPs are secreted by both inflammatory and con-
nective tissue cells such as fibroblasts, fibroblast-related cells,
chondrocytes, neutrophils, and monocytes/macrophages in
response to both infectious assaults and inflammatory
cytokines such as TNF-α and IL-1β [32,33]. The regulation of
MMP secretion is dependent on the cell type and stimulus.
Signal transduction pathways that involve the MAPK and pros-
taglandin E2/cyclic AMP pathways are considered to be cru-
cial, although the involvement of other pathways cannot be
ruled out [34,35]. The transcription factors c-jun (cellular
homologue of viral oncogene jun) and c-fos (cellular homo-
logue of FBJ murine sarcoma virus oncogene), members of the
AP-1 family, are involved in the transcription of MMP-1 and
these AP-1 factors are induced through MAPK signal trans-
duction. We determined the mRNA levels of some of the
MAPK family members in synovial fibroblasts from patients
with RA or OA treated with S. aureus and lysate culture super-
natant or IL-1β/TNFα. mRNAs for several of the MAPK family
members were upregulated by S. aureus lysates and culture
supernatants similar to those treated with IL-1β/TNF-α. Also,
the overall phosphotyrosine expression was enhanced in
fibroblasts treated with S. aureus components. The increase
in phosphotyrosine in fibroblasts treated with S. aureus com-
ponents or IL-1β/TNFα was comparable.
The importance of the proinflammatory cytokines TNF-α and
lymphotoxin (LT)-α in an experimental model of S. aureus sep-
sis and arthritis was examined by Hultgren and colleagues
[36]. Using TNF-α/LT-α-double-deficient mice, they showed
that in mice inoculated intravenously with a toxic shock syn-
drome toxin-1-producing S. aureus strain LS-1, mortality in
TNF-α/LT-α-deficient mice was 67%, with no mortality in the
controls. Those results correlated with a significantly
decreased phagocytosis in vitro and inefficient bacterial clear-
ance in vivo in mice lacking the capacity to produce TNF-α/LT-
α. Infection of mice with a lower dose of staphylococci
resulted in an overall low mortality, but the frequency of arthri-
tis was significantly higher in the wild-type group compared
with the TNF-α/LT-α-deficient mice (40% versus 13%). Syno-
vitis and erosivity were lower in TNF-α/LT-α-deficient mice
compared with wild-type controls. This study demonstrates
the detrimental role of TNF-α/LT-α as mediators of the
inflammatory response in S. aureus arthritis. TNF-α is a potent
inducer of several types of MMPs.
Figure 5
Induction of matrix metalloproteinase (MMP)-1 and MMP-3 mRNA in  response to Staphylococcus aureus components separated by molec- ular-weight difference Induction of matrix metalloproteinase (MMP)-1 and MMP-3 mRNA in 
response to Staphylococcus aureus components separated by molec-
ular-weight difference. Fractionated S. aureus culture supernatant (15 
μg/ml per well) obtained by centrifuging through Centricon filters with 
molecular-weight cutoff points <30 kDa, 30 to 50 kDa, and >50 kDa 
was added to confluent monolayers of dermal fibroblasts. Total RNA 
was isolated after 8 hours. The mRNA levels of MMP-1 and MMP-3 
were measured by SYBR green real-time reverse transcription-polymer-
ase chain reaction. The active components were mostly in the 30 to 50 
and >50 kDa molecular-weight range as evidenced by significantly ele-
vated expression of MMP-1 and MMP-3 by Centricon fractions 30 to 
50 and >50 kDa (p < 0.05; 30 to 50 kDa and >50 kDa fractions were 
compared with <30 kDa fractions).Arthritis Research & Therapy    Vol 8 No 6    Kanangat et al.
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Although IL-1 or TNF induced by S. aureus could very well be
contributing to the joint destruction (either through induction
of MMPs or through other degradative pathways), studies by
Kimura and colleagues [37] showed that blocking TNF and IL-
1 does not significantly prevent the late-stage destruction of
joint architecture in arthritis induced by S. aureus. In the
murine heat-killed S. aureus-induced arthritis model, TNF-α
and IL-1β peaked at 2 and 24 hours after the injection of heat-
killed S. aureus, respectively. Simultaneous administration of
anti-TNF-α monoclonal antibody (mAb) and IL-1 receptor
antagonist (IL-1ra) with S. aureus resulted in significant inhibi-
tion (80%) of 12-hour leukocyte infiltration. However, leuko-
cyte infiltration at 24 hours and beyond and the loss of
proteoglycan in S. aureus-induced arthritis were not affected
by anti-TNF-α mAb, IL-1ra, or their combination. These results
suggest that TNF-α and IL-1β involvement in the pathogenesis
of  S. aureus-induced arthritis may be limited to the initial
phases of inflammation. The authors suggested that suppress-
ing TNF-α and IL-1 may not be effective in the clinical treat-
ment of Gram-positive bacteria-induced arthritis.
With respect to the molecular pathways involved in S. aureus-
induced MMP expression in fibroblasts, our results suggest
that S. aureus components could use a pathway(s) similar to
that of IL-1β/TNF-α given that the MMP expression pattern,
MAPK gene expression, and phosphotyrosine levels were sim-
ilar in fibroblasts treated with S. aureus components or IL1β/
TNF-α. It is also important to note that S. aureus is capable of
inducing synthesis of inflammatory cytokines such as IL-1β
and TNF-α from host cells [13]. Whether the MMP induction
in fibroblasts by S. aureus component(s) is due to the
cytokine/chemokine induced by S. aureus is not known at
present. Previous studies by Wang and colleagues [31] have
shown that inhibitors of p38 MAPK (SB202190) and ERK1/2
(PD98059) and inhibitors of Src Tyrosine kinase (PP2) and
PI3-K (LY294002) effectively blocked PGN-mediated MMP-9
upregulation in neutrophils. The potential involvement of the
Toll-like receptor (TLR)-2 in S. aureus PGN-induced joint
inflammation and destruction was postulated in a study by
Kyburz and colleagues [18]. Cultured synovial fibroblasts
obtained from patients with RA or OA were stimulated with
PGN. The expression of various integrins was determined by
fluorescence-activated cell sorting. TLR-2 and MMP mRNAs
as measured by real-time PCR were upregulated in fibroblasts
treated with staphylococcal PGN. The levels of IL-6 and IL-8
in the culture supernatants were also increased by treatment
with PGN. We demonstrated that cultured synovial fibroblasts
express low levels of TLR-2 and TLR-9 mRNA. Anti-TLR-2
mAbs significantly inhibited production of IL-6 and IL-8
induced by stimulation with PGN. The authors concluded that
bacterial PGNs activate synovial fibroblasts, partially via TLR-
2, to express integrins, MMPs, and proinflammatory cytokines.
There was no mention regarding MMP expression after TLR
blockade, and it remains unclear whether TLR is involved in
MMP expression in a more direct way. Our preliminary results
have shown that S. aureus culture supernatant and whole cell
lysate induce the mRNA expression of several members of the
TLR family, including TLR-2 (data not shown).
To elucidate the MMP induction by S. aureus, we turned to
two well-characterized mutant strains of S. aureus lacking Sar
A and Agr. Agr and Sar are the two best-characterized loci
Figure 6
Matrix metalloproteinase (MMP) mRNA induction by staphylococcal accessory regulator (Sar), accessory gene regulator (Agr), and Sar/Agr mutants  of Staphylococcus aureus Matrix metalloproteinase (MMP) mRNA induction by staphylococcal accessory regulator (Sar), accessory gene regulator (Agr), and Sar/Agr mutants 
of Staphylococcus aureus. MMP-1 and MMP-3 mRNAs in confluent monolayers of human dermal fibroblasts exposed to 25 μg of total protein/well 
per milliliter from cell lysate and 25 μg/well per milliliter of total protein from culture supernatants (SUP) of parent (U1) mutant strains (U155 Sar-/-; 
U929 Agr-/-; U930 Sar/Agr-/-) were measured by SYBR green real-time reverse transcription-polymerase chain reaction 8 hours after exposure. No 
significant differences in mRNA levels of MMP-1 and MMP-3 induced by the mutants and their isogenic parent strain were observed.Available online http://arthritis-research.com/content/8/6/R176
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responsible for modulating the expression of S. aureus viru-
lence factors [38]. S. aureus strains lacking either locus have
been shown to result in attenuation of S. aureus in several
models of staphylococcal diseases [39-41]. Recent investiga-
tions by Blevins and colleagues [19] have also shown that
mutation of Sar A and/or Agr caused reduced capacity to
induce both SA and osteomyelitis. The exact mechanisms of
reduced effectiveness of Sar/Agr  mutants to cause SA or
osteomyelitis are not known. Studies by Nilsson and col-
leagues [41] showed that mice inoculated with the Sar A+ sta-
phylococcal strain exhibited a more pronounced T- and B-
lymphocyte activation and higher levels of serum IL-6 and IFN-
γ, compared with a Sar A-/- mutant, and infection with Sar A+
staphylococci induced pronounced weight loss as well. These
studies suggested that Sar A locus might control molecules
that are important virulence determinants in the induction and
progression of SA. We therefore tested the MMP-1, -3, and -
13 expression patterns in response to Sar, Agr, or Sar/Agr
mutants in human dermal fibroblasts. The three MMPs were
selected due to their known involvement in various models of
arthritis and their respective degrading actions on collagen
type I, II, and III and proteoglycan, which are important constit-
uents of connective tissues and cartilage of the joints. Our
results did not show any significant differences in MMP-1 and
MMP-3 mRNA levels, and 13 mRNA levels were minimal and
could not be quantified with reasonable accuracy in dermal
fibroblasts upon exposure to culture supernatants or cell
lysates obtained from the mutants and isogenic parent strain
(Figure 6). However, interestingly, the expression of TIMPs
was notably increased in fibroblasts treated with Sar/Agr
Figure 7
Enhanced expression of tissue inhibitor of metalloproteinases (TIMP) mRNAs in human dermal fibroblasts treated with culture supernatants (a) and  whole bacterial cell lysates (b) obtained from Sar A-/- and Sar A-/-Agr-/- mutants of Staphylococcus aureus and isogenic parent strain Enhanced expression of tissue inhibitor of metalloproteinases (TIMP) mRNAs in human dermal fibroblasts treated with culture supernatants (a) and 
whole bacterial cell lysates (b) obtained from Sar A-/- and Sar A-/-Agr-/- mutants of Staphylococcus aureus and isogenic parent strain. Culture super-
natants and cell lysates obtained from an S. aureus strain isolated from synovial fluid of a septic arthritis patient (obtained from American Type Cul-
ture Collection, Manassas, VA, USA), a clinical isolate (U1), its Sar A mutant (U929), and Agr/Sar A double-loci-deleted mutant (U930) (strains 
obtained from M. Smeltzer) were used. Equal amounts of total protein from all samples were added to confluent monolayers of fibroblast cultures. 
Total RNA was harvested from the cells 12 hours after exposure to the supernatants. The levels of TIMP-1, -2, and -3 mRNAs were estimated by real-
time SYBR green reverse transcription-polymerase chain reaction. The values plotted represent the ratios of the threshold cycle values of TIMPs to 
that of the housekeeping gene GAPDH (glyceraldehyde phosphate dehydrogenase). Agr, accessory gene regulator; Sar, staphylococcal accessory 
regulator; SUP, culture supernatant.Arthritis Research & Therapy    Vol 8 No 6    Kanangat et al.
Page 12 of 14
(page number not for citation purposes)
mutants compared with isogenic parent strain (Figure 7a,b).
This could mean that the effective biologically active MMPs are
less abundant in cells treated with the Sar/Agr mutants com-
pared with cells treated with isogenic parent strain. It will be
necessary to estimate the levels of biologically active MMPs
(by zymograms) to determine the net effect of Sar/Agr mutants
on MMP expression. Temporal estimation of biologically active
MMPs in the joints after infection with isogenic parent and
mutants will help to clarify the issue of MMPs as a factor in the
observed differences in severity of diseases caused by wild-
type and mutant strains. Bacteria may secrete proteolytic
enzymes such as the thermolysin family secreted by Pseu-
domonas aeruginosa and Vibrio cholera which activate pro-
MMP-1, -8, and -9 [42]. Also, proteases from the oral patho-
gen  Porphyromonas gingivalis activate MMP-1, -3, and -9
[43]. If the bacterial-derived proteases are required for viru-
lence, such proteases can be attractive therapeutic targets
because their inhibition can be achieved without affecting the
normal expression and function of MMPs. There are reports of
other staphylococcal virulence factors associated with the
pathogenesis and severity of SA [43-45]. Whether these viru-
lence factors are associated with MMP/TIMP expression
remains to be seen.
In addition to the bone and joint infections, S. aureus is also
the prime causative agent in many skin and soft tissue infec-
tions (SSTIs), which can be manifested as superficial to deep-
seated and at times become life-threatening [46-48]. Due to
lack of validated clinical evidence, it is often difficult to recom-
Figure 8
Mitogen-activated protein kinase (MAPK) family mRNA expression pro- file in human dermal fibroblasts (a) and human synovial fibroblasts (b)  exposed to Staphylococcus aureus whole cell lysate and filtered cul- ture supernatant Mitogen-activated protein kinase (MAPK) family mRNA expression pro-
file in human dermal fibroblasts (a) and human synovial fibroblasts (b) 
exposed to Staphylococcus aureus whole cell lysate and filtered cul-
ture supernatant. Confluent monolayers of de-identified human dermal 
fibroblasts from normal volunteer and synovial fibroblasts from a patient 
with rheumatoid arthritis were treated with 25 μg/ml per well of S. 
aureus whole lysate, filtered culture supernatant, and a combination of 
rhIL-1β and TNF-α (10 ng/ml each) for 8 hours. Cells were harvested 
and total cellular RNA was isolated and reverse-transcribed. The MAPK 
family gene expression was analyzed using the Human MAPK Gene 
Family I Multigene-12 reverse transcription-polymerase chain reaction 
(PCR) profiling kit. The semiquantitative values were generated by 
determining the ratios of the band intensities of respective PCR prod-
ucts to that of housekeeping gene GAPDH (glyceraldehyde phosphate 
dehydrogenase) in each sample. The experiments were repeated three 
times. The band densities were determined using three-dimensional 
densitometric scanning software from Alpha Innotech Corporation (San 
Leandro, CA, USA). Of the 11 tested Human MAPK Family I genes 
(ERK1, ERK2, MAPK2/4, ERK3, ERK5, JNK1, JNK2, JNK3, p38b 
MAPK, p38g MAPK, and p38delta), ERK1, ERK2, JNK1, JNK2, 
MAPK4, and p38b were elevated significantly in both dermal and syno-
vial fibroblasts upon exposure to S. aureus components (p < 0.05 for 
individual MAPK gene family member when values from untreated 
fibroblasts and treated fibroblasts were compared). The response was 
similar in both cell lines in response to IL-1/TNF. ERK, extracellular sig-
nal regulated kinase; IL, interleukin; JNK, c-jun N-terminal kinase; SUP, 
filtered culture supernatant; TNF, tumor necrosis factor.
Figure 9
Tyrosine phosphorylation in human dermal fibroblasts exposed to Sta- phylococcus aureus culture supernatant Tyrosine phosphorylation in human dermal fibroblasts exposed to Sta-
phylococcus aureus culture supernatant. Using a cell-based enzyme-
linked immunosorbent assay system (RayBiotech, Inc., Norcross, GA, 
USA), tyrosine phosphorylation was assessed in human dermal fibrob-
lasts exposed to 25 μg of total protein/ml from filtered culture superna-
tant of S. aureus, 25 μg/ml total protein from S. aureus cell pellet 
lysate, and in fibroblasts treated with 10 ng/ml each of rhIL-1β and 
rhTNF-α. These assays were carried out in 96-well plates supplied by 
the manufacturer. The cells were exposed to various agents for 30 min-
utes before assaying for tyrosine phosphorylation. The assays were car-
ried out in triplicate. There was significant increase in tyrosine 
phosphorylation in S. aureus culture supernatant-treated cells similar to 
IL-1β/TNF-α-treated cells compared with untreated fibroblasts (p < 
0.05). IL, interleukin; OD, optical density; SUP, culture supernatant; 
TNF, tumor necrosis factor.Available online http://arthritis-research.com/content/8/6/R176
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mend general treatment options [49]. The pathogenesis of
SSTI is not understood well, and the treatment is guided
mostly by epidemiological pattern and microbiological infor-
mation [50]. Due to the emergence of MRSA, it is important to
understand the mechanisms of tissue destruction in soft tissue
infections which could lead on the identification of novel ther-
apeutic targets. Our current in vitro data and the in vivo data
reported previously by others implicate that host-derived met-
alloproteinases could be involved, at least in part, in tissue
destruction. Excessive expression of these metalloproteinases
induced by S. aureus could lead to the destruction of the soft
tissue connective tissue architecture.
Conclusion
We have shown that S. aureus is a potent inducer of multiple
MMPs in human dermal and synovial fibroblasts. Our studies
also indicate that MAPK-mediated signal transduction path-
way involving proteins that are phosphorylated at tyrosine res-
idues might play a role in S. aureus-induced MMP expression.
Enhanced expression of immunoreactive MMPs by cell lysate
obtained from S. aureus grown in the presence of rhIL-1 indi-
cates that an inflamed milieu such as RA synovium might aug-
ment the MMP induction potential of S. aureus. More specific
identification of the component(s) of S. aureus involved in the
upregulation of MMP and associated signal transduction path-
ways may help in identifying novel targets for intervention.
Based on our results, we propose that biologically active
MMPs (reflected as a ratio of MMPs to TIMPs) induced by S.
aureus could potentially accelerate the joint destruction in SA.
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